Davidson Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.31M Buy
5,259
+154
+3% +$157K 1.01% 21
2026
Q1
$4.7M Buy
5,105
+42
+0.8% +$42.6K 0.85% 36
2025
Q4
$5.44M Sell
5,063
-112
-2% -$107K 1.18% 9
2025
Q3
$3.95M Buy
5,175
+1,150
+29% +$856K 0.88% 25
2025
Q2
$3.14M Buy
4,025
+100
+3% +$77.7K 0.75% 43
2025
Q1
$3.24M Sell
3,925
-372
-9% -$310K 0.88% 16
2024
Q4
$3.32M Buy
4,297
+759
+21% +$628K 0.87% 32
2024
Q3
$3.13M Sell
3,538
-493
-12% -$443K 0.9% 32
2024
Q2
$3.65M Buy
4,031
+789
+24% +$631K 1.13% 8
2024
Q1
$2.52M Buy
+3,242
New +$2.31M 0.81% 36
2023
Q1
Sell
-6
Closed -$2.19K 121
2022
Q4
$2.19K Buy
+6
New +$2.13K ﹤0.01% 116

Other funds holding LLY

Davidson Capital Management's LLY Position: Q2 2026 in Review

Davidson Capital Management increased its Eli Lilly (LLY) stake by 3% in Q2 2026, buying an estimated $157K and bringing the position to 5,259 shares worth $6.31M. The position accounts for 1.01% of the portfolio, ranked #21.

Davidson Capital Management first reported a position in LLY in Q4 2022 and has held it in 11 quarters since. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Davidson Capital Management held 5,259 shares of Eli Lilly worth $6.31M as of Q2 2026.
  • Davidson Capital Management bought 154 Eli Lilly shares in Q2 2026, an estimated $157K.
  • Eli Lilly made up 1.01% of Davidson Capital Management's portfolio in Q2 2026, its #21 holding.
  • Davidson Capital Management first reported a position in Eli Lilly in Q4 2022 and has held it in 11 quarters since.
  • 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Davidson Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.